Effect of Madhuyashtyadi Taila Matra Basti in Patients suffering from Vatarakta (Gout)

A Prospective Open Label Controlled Clinical Study to Determine the Efficacy of Madhuyashtyadi Taila Matra Basti in the Management of Vatarakta with Special Reference to Gout - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/109914

Enrollment

Registered

2026-05-04

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M100- Idiopathic gout

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients indicated for Basti therapy (Basti Arha). 2. Diagnosed cases of Vatarakta presenting with classical features like Sandhishool (pain), Daha (burning sensation), Shotha (swelling), and Stambha (stiffness).

Exclusion criteria

Exclusion criteria: 1. Patients contraindicated for Basti therapy (Basti Anarha). 2. Patients below 30 years or above 60 years of age. 3. Patients of Vatarakta having any chronic systemic disorder which interferes with the present study, such as chronic heart disease, chronic renal disorders, or history of previous intestinal surgery. 4. Pregnant and lactating women. 5. Patients on allopathic uric acid lowering medications and corticosteroids.

Design outcomes

Primary

Measure	Time frame
Vatarakta symptom scoresTimepoint: Day 0 Day 8 Day 15 Day 30	—

Secondary

Measure	Time frame
serum uric acidTimepoint: Day 0 Day 30	—

Countries

India

Contacts

Public ContactDr Jeevan Sampat Jadhav

Shree Saptashrungi Ayurved Mahavidyalay and Hospital ,Nashik

ravindrasphadol@gmail.com9975641619

Outcome results